Videos | Radial Access | May 06, 2021

VIDEO: Radial Hemostasis Reduced by 50 Percent With StatSeal in Combination With TR Band

Arnold Seto, M.D., MPA, FSCAI, chief of cardiology, Long Beach Veterans Affairs Medical Center and director, interventional cardiology research, UCI Health, and Jordan Safirstein, M.D., FSCAI, director of transradial intervention, Atlantic Health's Morristown Medical Center, were involved in a physician-initiated study to find a new way to cut radial artery access site hemostasis by 50 percent. The late-breaking study presented at SCAI 2021 uses a combination of a StatSeal patch and the TR Band compression bracelet.

Cardiac catherization is increasingly bing performed using transradial approach, now making up 50 percent or more of the access used for U.S. interventional procedures. The Terumo TR Band is used to close the vascular access site. Standard protocols require the band to be left on for at least two hours following the procedure. 

Shorter compression times can help reduce complications with radial artery occlusion, so it is desirable to find ways to shorten compression times, Seto said. He explained clinicians often start to deflate the wrist band balloon after an hour and watch for ooze or blood. If there are signs the wound is not completely sealed, the band is reinflated. Reinflations occurs more that 67 percent of the time, he explained.

"We found with the Statseal, you almost never have to reinflate," Seto said. 

This study shows that time can be reduced in half and with fewer complications by using the additional patch device, which helps sped the clotting process. This can save staff time and possibly leading to faster patient discharge for same-day PCI programs. 

Read more in the article Radial Hemostasis Time Cut by 50 Percent With StatSeal in Combination With TR Band.

SCAI 2021 Late-breaking Clinical Study Results

Find more news from the SCAI 2021 virtual meeting


Recent Videos View all 644 items

Womens Cardiovascular Health | February 01, 2023

Managing Acute Coronary Syndromes in Women: Why and When is a Unique Approach Required features an in-depth interview with Malissa J. Wood, MD, FACC. Wood is the co-director of the Corrigan Women’s Heart Health Program at Massachusetts General Hospital Heart Center, and associate professor at Harvard Medical School. Here, she offers detailed guidance to cardiologists for improving the diagnosing and treatment of heart disease in women. Wood serves as the American College of Cardiology, ACC Chair, Board of Governors, and Secretary, Board of Trustees (2022-2023). This video interview is part of DAIC's One on One ... feature series that profiles a leader in cardiology to share insight, updates and initiatives on a range of hot topics impacting the cardiology community. The series also includes a feature profile and podcast.

Related content:

VIDEO: Precision Cardiovascular Medicine: The Next Frontier in Patient Care and Innovation

VIDEO: Unique Features of Coronary Artery Disease in Women

Treatment for Heart Attacks Improving but Gaps in Access Persist, New Study Shows

Closing the Gap in Healthcare by Addressing Gender Bias 

Diagnostic Differences in Women’s Heart Health  

VIDEO: Differences in Cardiac Complications and Presentation Between Men and Women — Interview with Cindy Grines, M.D.  

DAIC's Women's Cardiovascular Health Channel  

VIDEO: How to Build a Successful Women’s Heart Center — Interview with Malissa Wood, M.D.  

VIDEO: Creating a Cardio-Obstetrics Team — Doreen DeFaria Yeh, M.D. 

Related Content on New Technology and Ideas to Address Health Disparities: 

VIDEO: New Ideas in Addressing Cardiovascular Disease Disparities — Clyde Yancy, M.D 

VIDEO: How Smartphones May Revolutionize Healthcare in the Developing World —Interview with Jacques Kpodonu, M.D. 

VIDEO: Reducing Hypertension Among African-Americans — Interview with Kim Allan Williams, Sr., M.D. 

Sponsored Videos View all 46 items

Cardiovascular Ultrasound | July 20, 2022

Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.  

Watch the video to check out how TrueVue can help improve views of LAA and MV morphology. 

Cardiovascular Ultrasound | July 07, 2022

Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*  

Watch the video to see how you can put “smart”  to work with the latest AI-powered quantification tools. 

*External study with external sonographers comparing the results of 18 exams with and without AutoMeasure

Cardiovascular Ultrasound | June 14, 2022

The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer. 

Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more. 

Cardiovascular Ultrasound | May 31, 2022

Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.

Conference Coverage View all 460 items

Cath Lab View all 316 items

Cardiac Imaging View all 287 items

Cardiac Diagnostics View all 78 items

EP Lab View all 83 items

Information Technology View all 169 items

Subscribe Now